BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 31522437)

  • 21. Regulation of an autoimmune model for multiple sclerosis in Th2-biased GATA3 transgenic mice.
    Fernando V; Omura S; Sato F; Kawai E; Martinez NE; Elliott SF; Yoh K; Takahashi S; Tsunoda I
    Int J Mol Sci; 2014 Jan; 15(2):1700-18. PubMed ID: 24463292
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early IFN-γ production together with decreased expression of TLR3 and TLR9 characterizes EAE development conditional on the presence of myelin.
    Evangelista MG; Castro SB; Alves CC; Dias AT; Souza VW; Reis LB; Silva LC; Castañon MC; Farias RE; Juliano MA; Ferreira AP
    Autoimmunity; 2016 Jun; 49(4):258-67. PubMed ID: 26911613
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nobiletin attenuates inflammation via modulating proinflammatory and antiinflammatory cytokine expressions in an autoimmune encephalomyelitis mouse model.
    Yarim GF; Yarim M; Sozmen M; Gokceoglu A; Ertekin A; Kabak YB; Karaca E
    Fitoterapia; 2022 Jan; 156():105099. PubMed ID: 34896483
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Establishment and characterization of an optimized mouse model of multiple sclerosis-induced neuropathic pain using behavioral, pharmacologic, histologic and immunohistochemical methods.
    Khan N; Woodruff TM; Smith MT
    Pharmacol Biochem Behav; 2014 Nov; 126():13-27. PubMed ID: 25223977
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunomodulatory effects and improved prognosis of experimental autoimmune encephalomyelitis after O-tetradecanoyl-genistein treatment.
    Castro SB; Junior CO; Alves CC; Dias AT; Alves LL; Mazzoccoli L; Mesquita FP; Figueiredo NS; Juliano MA; Castañon MC; Gameiro J; Almeida MV; Teixeira HC; Ferreira AP
    Int Immunopharmacol; 2012 Feb; 12(2):465-70. PubMed ID: 22245971
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Brain inflammation in experimental autoimmune encephalomyelitis induced in Dark Agouti rats with spinal cord homogenate.
    Stegnjaić G; Jevtić B; Lazarević M; Ignjatović Đ; Tomić M; Nikolovski N; Bjelobaba I; Momčilović M; Dimitrijević M; Miljković Đ; Stanisavljević S
    Immunol Lett; 2024 Jun; 267():106852. PubMed ID: 38508497
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protracted, relapsing and demyelinating experimental autoimmune encephalomyelitis in DA rats immunized with syngeneic spinal cord and incomplete Freund's adjuvant.
    Lorentzen JC; Issazadeh S; Storch M; Mustafa MI; Lassman H; Linington C; Klareskog L; Olsson T
    J Neuroimmunol; 1995 Dec; 63(2):193-205. PubMed ID: 8550817
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of Oenothera biennis L. and Hypericum perforatum L. extracts on some central nervous system myelin proteins, brain histopathology and oxidative stress in mice with experimental autoimmune encephalomyelitis.
    Selek S; Esrefoglu M; Meral I; Bulut H; Caglar HG; Sonuc G; Yildiz C; Teloglu ES; Dogan N; Yuce B; Tiftik E; Bayindir N
    Biotech Histochem; 2019 Feb; 94(2):75-83. PubMed ID: 30957550
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alterations of peripheral nerve excitability in an experimental autoimmune encephalomyelitis mouse model for multiple sclerosis.
    Teixeira NB; Picolo G; Giardini AC; Boumezbeur F; Pottier G; Kuhnast B; Servent D; Benoit E
    J Neuroinflammation; 2020 Sep; 17(1):266. PubMed ID: 32894170
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mice overexpressing Bcl-2 in their neurons are resistant to myelin oligodendrocyte glycoprotein (MOG)-induced experimental autoimmune encephalomyelitis (EAE).
    Offen D; Kaye JF; Bernard O; Merims D; Coire CI; Panet H; Melamed E; Ben-Nun A
    J Mol Neurosci; 2000 Dec; 15(3):167-76. PubMed ID: 11303781
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic approach by Aloe vera in experimental model of multiple sclerosis.
    Mirshafiey A; Aghily B; Namaki S; Razavi A; Ghazavi A; Ekhtiari P; Mosayebi G
    Immunopharmacol Immunotoxicol; 2010 Sep; 32(3):410-5. PubMed ID: 20233107
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inconsistence between number and function of autoreactive T cells in the course of experimental autoimmune encephalomyelitis.
    Wan X; Pei W; Zhang Y; Zhang L; Shahzad KA; Xu T; Shen C
    Immunol Invest; 2018 Jan; 47(1):1-17. PubMed ID: 28872930
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early axonal damage and progressive myelin pathology define the kinetics of CNS histopathology in a mouse model of multiple sclerosis.
    Recks MS; Stormanns ER; Bader J; Arnhold S; Addicks K; Kuerten S
    Clin Immunol; 2013 Oct; 149(1):32-45. PubMed ID: 23899992
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Archeological neuroimmunology: resurrection of a pathogenic immune response from a historical case sheds light on human autoimmune encephalomyelitis and multiple sclerosis.
    Beltrán E; Paunovic M; Gebert D; Cesur E; Jeitler M; Höftberger R; Malotka J; Mader S; Kawakami N; Meinl E; Bradl M; Dornmair K; Lassmann H
    Acta Neuropathol; 2021 Jan; 141(1):67-83. PubMed ID: 33242149
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparative study of experimental mouse models of central nervous system demyelination.
    Dumitrascu OM; Mott KR; Ghiasi H
    Gene Ther; 2014 Jun; 21(6):599-608. PubMed ID: 24718267
    [TBL] [Abstract][Full Text] [Related]  

  • 36. St. John's wort and its component hyperforin alleviate experimental autoimmune encephalomyelitis through expansion of regulatory T-cells.
    Nosratabadi R; Rastin M; Sankian M; Haghmorad D; Tabasi N; Zamani S; Aghaee A; Salehipour Z; Mahmoudi M
    J Immunotoxicol; 2016 May; 13(3):364-74. PubMed ID: 26634391
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Secondary B cell receptor diversification is necessary for T cell mediated neuro-inflammation during experimental autoimmune encephalomyelitis.
    Galicia G; Boulianne B; Pikor N; Martin A; Gommerman JL
    PLoS One; 2013; 8(4):e61478. PubMed ID: 23613859
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MOG-induced experimental autoimmune encephalomyelitis in the rat species triggers anti-neurofascin antibody response that is genetically regulated.
    Flytzani S; Guerreiro-Cacais AO; N'diaye M; Lindner M; Linington C; Meinl E; Stridh P; Jagodic M; Olsson T
    J Neuroinflammation; 2015 Oct; 12():194. PubMed ID: 26511327
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low-level laser therapy ameliorates disease progression in a mouse model of multiple sclerosis.
    Gonçalves ED; Souza PS; Lieberknecht V; Fidelis GS; Barbosa RI; Silveira PC; de Pinho RA; Dutra RC
    Autoimmunity; 2016; 49(2):132-42. PubMed ID: 26703077
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment with a recombinant human IgM that recognizes PSA-NCAM preserves brain pathology in MOG-induced experimental autoimmune encephalomyelitis.
    Lemus HN; Warrington AE; Denic A; Wootla B; Rodriguez M
    Hum Antibodies; 2017; 25(3-4):121-129. PubMed ID: 28269761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.